Copyright
©The Author(s) 2023.
World J Gastroenterol. Jun 28, 2023; 29(24): 3855-3870
Published online Jun 28, 2023. doi: 10.3748/wjg.v29.i24.3855
Published online Jun 28, 2023. doi: 10.3748/wjg.v29.i24.3855
Figure 3 The correlation between the optimal variables and thalidomide-induced peripheral neuropathy.
Illustrate patients with interleukin-12 rs1353248_TT, brain-derived neurotrophic factor (BDNF) rs2030324_AG, BDNF rs6265_CT, and BDNF rs11030104_AG, genotypes are more likely to have thalidomide-induced peripheral neuropathy than non-carriers. A: IL-12; B-D: BDNF. aP < 0.01, bP < 0.001. BDNF: Brain-derived neurotrophic factor; IL: Interleukin.
- Citation: Mao J, Chao K, Jiang FL, Ye XP, Yang T, Li P, Zhu X, Hu PJ, Zhou BJ, Huang M, Gao X, Wang XD. Comparison and development of machine learning for thalidomide-induced peripheral neuropathy prediction of refractory Crohn’s disease in Chinese population. World J Gastroenterol 2023; 29(24): 3855-3870
- URL: https://www.wjgnet.com/1007-9327/full/v29/i24/3855.htm
- DOI: https://dx.doi.org/10.3748/wjg.v29.i24.3855